Navigation Links
Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
Date:6/2/2009

PRINCETON, N.J., June 2 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces management will present at the Goldman Sachs Global Healthcare Conference and the Needham Healthcare Conference. Both conferences will be held in New York, NY.

Schaefer Price, Pharmasset's President and Chief Executive Officer, will provide an overview of the company at the Goldman Sachs Global Healthcare Conference on Tuesday, June 9, 2009 at 3:10 PM (ET) and at the Needham Conference on Thursday June 11, 2009 at 1:00 PM (ET).

To access a simultaneous webcast of Mr. Price's overview via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm. Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast.

A replay of the webcast will be available on Pharmasset's website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the developme
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
2. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
3. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
4. Pharmasset Reports Fiscal Year End 2008 Financial Results
5. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
6. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
7. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
8. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
9. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)...  PowerVision, Inc., a medical device company developing ... announced that Douglas D. Koch , M.D., ... and Professor of Ophthalmology, at Baylor College of ... As a recipient of several ... Lifetime Achievement award, Koch will join the distinguished ...
(Date:7/21/2014)... July 21, 2014  AVT, Inc. (OTC Markets: ... retailing, micro-stores, custom vending machines and kiosks, commented ... medicine dispensing systems, which can be used by ... marijuana dispensaries. AVT,s newly designed systems provide for ... and regulated products. "We are getting ...
(Date:7/21/2014)... July 21, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... and Drug Administration (FDA) accepted the company,s Investigational New ... the safety and efficacy of AVP-786, Avanir,s next generation ... AVP-786 for the adjunctive treatment of major depressive disorder ... "The endorsement of this Phase II study ...
Breaking Medicine Technology:PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 2PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 3PowerVision Appoints Ophthalmology Thought Leader Douglas D. Koch, M.D. to its Scientific Advisory Board 4Technology Driving Cannabis Industry 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5
(Date:7/21/2014)... Riverdale, NJ (PRWEB) July 22, 2014 On ... 7th Annual Charity Golf Outing honoring Mike McGuriman-Motorola Solutions at ... NJ. The outing begins with registration and lunch at 11 ... lunch, dinner and prizes. Price increases to $250 after ... dinner tickets for $100 per person. The dinner will ...
(Date:7/21/2014)... As reported by CBS Local Pittsburgh in ... Addiction Awareness (7/15), thrill-seeking participants raised $100,000 to raise ... in Downtown Philly. 100 people, including some well-known local ... Convention Center Hotel. Some of the participants shared stories ... because his son killed himself after a long battle ...
(Date:7/21/2014)... 2014 The League of Voluntary Hospitals ... Healthcare Workers East (“1199SEIU”) today announced a new tentative ... healthcare providers and their employees. , Under the ... by League and 1199SEIU members, employee wages will rise ... existing worker benefits, including healthcare coverage with no out ...
(Date:7/21/2014)... 2014 Ticket Down is a ... at the Sun Life Stadium in Miami Gardens, Florida on ... Brazil and Argentina is one that has been going on ... are forming with each passing day. One rivalry that will ... and another South American nation, Colombia. The two teams saw ...
(Date:7/21/2014)... Ticket Down is a reliable source for cheap LA ... One of the best club teams in the world of football, ... Champions Cup, which is set to begin later this month across ... get a chance to fine tune their lineup for the tournament ... the Chevrolet Cup where they will take on the L.A. Galaxy ...
Breaking Medicine News(10 mins):Health News:7th Annual Push to Walk Golf Outing to Be Held September 22nd 2Health News:100 People Climb Down Building to Raise Drug Addiction Awareness in Philadelphia 2Health News:100 People Climb Down Building to Raise Drug Addiction Awareness in Philadelphia 3Health News:League of Voluntary Hospitals and Homes and 1199SEIU Reach New Four-Year Collective Bargaining Agreement 2Health News:League of Voluntary Hospitals and Homes and 1199SEIU Reach New Four-Year Collective Bargaining Agreement 3Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Reports Huge Demand for Colombia vs. Brazil Tickets at Sun Life Stadium in Miami in Early September 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Reports Huge Demand for Colombia vs. Brazil Tickets at Sun Life Stadium in Miami in Early September 3Health News:LA Galaxy vs. Manchester United Tickets Rose Bowl: Ticket Down Cuts Chevrolet FC Cup Ticket Prices For ManU vs. LA Galaxy in Pasadena on July 23rd 2Health News:LA Galaxy vs. Manchester United Tickets Rose Bowl: Ticket Down Cuts Chevrolet FC Cup Ticket Prices For ManU vs. LA Galaxy in Pasadena on July 23rd 3
... for patients in just the first six months after they ... in Canada, according to a study presented today at the ... Ischemic Stroke (BURST) study found that the direct and indirect ... in the six-month period following a new stroke. There are ...
... June 8, 2010The new Center for Medicare and Medicaid ... and implementing payment initiatives, continuously monitor their impact, and ... in order to realize the potential for improved health ... Health Affairs article by Commonwealth Fund researchers. ...
... (June 7, 2010) Researchers from the BC Centre ... British Columbia today released a comprehensive study revealing that ... would create significant benefits for individuals infected with HIV ... modeling study, published in the research journal PLoS ...
... at Purdue University have developed a potential new tool ... and crime-scene forensics. The technique uses a combination ... tiny particles, such as bacteria, viruses and DNA, which ... either light or electric fields separately are able to ...
... target cancerous plasma cells appears promising in treating multiple myeloma, ... at the drug elotuzumab, an antibody which is designed to ... cells. The antibody has the potential to attach to malignant ... early stage trial combined elotuzumab with bortezomib, or Velcade, one ...
... common in younger men, and it,s often more aggressive in ... of Michigan Comprehensive Cancer Center has found that a series ... cancer. Researchers believe that genetics and traditional screening methods ... cancer in younger men. "This is a potential ...
Cached Medicine News:Health News:Cost of caring for stroke patients double that of earlier estimates 2Health News:Cost of caring for stroke patients double that of earlier estimates 3Health News:Center for Medicare and Medicaid Innovation must implement payment reforms rapidly 2Health News:Center for Medicare and Medicaid Innovation must implement payment reforms rapidly 3Health News:Updated HIV therapy guidelines would reduce risk of transmission, save lives, billions in costs 2Health News:Updated HIV therapy guidelines would reduce risk of transmission, save lives, billions in costs 3Health News:New method manipulates particles for sensors, crime scene testing 2Health News:New method manipulates particles for sensors, crime scene testing 3
... base with vacuum stage, porous vacuum plate, reservoir ... instructions. The Model 785 vacuum blotter quickly ... agarose gel onto a nylon membrane. Because it ... nucleic acid samples can be separated on a ...
... regulator. The Model 785 vacuum blotter ... from an agarose gel onto a nylon ... min for transfer, the nucleic acid samples ... to a membrane, and the hybridization reaction ...
Inquire...
... proven electrophoretic transfer apparatus incorporating state-of-the-art plate electrodes ... allows for a very close positioning of the ... power source such as a battery charger, creates ... exceptionally rapid and exact electrophoretic transfer. ...
Medicine Products: